Fortrea Competitors and Similar CompaniesClear all
Fortrea's competitors and similar companies include Pfizer, SYNthesis Med Chem, Terns Pharmaceuticals and Orbit Discovery.
 Fortrea Fortrea Holdings (formerly known as Labcorp Clinical Development and Commercialization Services) is a contract research organization (CRO). |  Pfizer Pfizer is a research-based biopharmaceutical company engaged in the discovery, development, manufacture, and distribution of healthcare products. |  SYNthesis Med Chem SYNthesis Med Chem is a chemistry contract research organization that provides small molecule drug discovery services. |  Terns Pharmaceuticals Terns Pharmaceuticals is a biopharmaceutical company developing small-molecule single-agent and combination therapy for the treatment of non-alcoholic steatohepatitis and other chronic liver diseases. |  Orbit Discovery Orbit Discovery is a biopharmaceutical company focused on discovering candidate peptide therapeutics. | |
Founding Date | Founding Date 2023 | Founding Date 1849 | Founding Date 2007 | Founding Date 2017 | Founding Date 2015 |
Type | Type Public | Type Public | Type Private | Type Public | Type Private |
Tags | |||||
Locations | Locations Durham, US HQ Buenos Aires, AR Melbourne, AU Sydney, AU Zaventem, BE Sao Paulo, BR Sofia, BG see more | Locations New York, US HQ Buenos Aires, AR Villa Adelina, AR Footscray, AU Mulgrave, AU Sydney, AU Wien, AT see more | Locations Parkville, AU HQ Parkville, AU Suzhou Shi, CN Alderley Edge, GB San Diego, US | Locations Foster City, US HQ | Locations Oxford, GB HQ London, GB Oxford, GB |
Employees | Employees 19,000 | Employees 81,0008% decrease | Employees 166% decrease | Employees 59 | Employees 31 |
Valuation ($) | Valuation ($) 1.6 b | Valuation ($) 163.9 b | Valuation ($) N/A | Valuation ($) 580.9 m | Valuation ($) N/A |
Financial | |||||
Revenue (est.) | Revenue (est.) $2.7b (FY, 2025) | Revenue (est.) $62.6b (FY, 2025) | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) N/A |
Net income | Net income ($986.2m) (FY, 2025) | Net income $7.8b (FY, 2025) | Net income N/A | Net income ($96.2m) (FY, 2025) | Net income N/A |
Operating ⚠ | |||||
Countries | Countries 90 (Jul, 2023) | Countries 200 (FY, 2024) | Countries N/A | Countries N/A | Countries N/A |
Funding | |||||
Total funding raised | Total funding raised N/A | Total funding raised N/A | Total funding raised N/A | Total funding raised $ 30m | Total funding raised $ 17m |
For sources of this data, please see the company profile
View Company Profiles
Pfizer
HQ
New York, US
Employees
81,000↓ 8% decrease
Pfizer is a research-based biopharmaceutical company engaged in the discovery, development, manufacture, and distribution of healthcare products.
View companySYNthesis Med Chem
HQ
Parkville, AU
Employees
16↓ 6% decrease
SYNthesis Med Chem is a chemistry contract research organization that provides small molecule drug discovery services.
View companyTerns Pharmaceuticals
HQ
Foster City, US
Employees
59
Terns Pharmaceuticals is a biopharmaceutical company developing small-molecule single-agent and combination therapy for the treatment of non-alcoholic steatohepatitis and other chronic liver diseases.
View companyOrbit Discovery
HQ
Oxford, GB
Employees
31
Orbit Discovery is a biopharmaceutical company focused on discovering candidate peptide therapeutics.
View company